# Ketamine and Postoperative Cognitive Dysfunction

> **NCT02892916** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 307 (actual)

## Conditions studied

- Post Operative Cognitive Dysfunction

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02892916
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2019-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892916, "Ketamine and Postoperative Cognitive Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02892916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*